Retinal Vasculitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Retinal Vasculitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

RecruitingNot Applicable

NCT07206238

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

Giant cell arteritis (GCA) is an inflammation of the blood vessels. A dangerous complication is sudden vision loss due to insufficient blood supply to the optic…

Denmark122 participantsStarted 2026-01-14

Treatment: Positron Emission Tomography / Magnetic Resonance Imaging

RecruitingNot Applicable

NCT07065747

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased…

United States125 participantsStarted 2024-09-01

RecruitingNot Applicable

NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…

United States, Australia20,000 participantsStarted 2010-07

RecruitingNot Applicable

NCT06500728

Visual Involvement in Giant Cell Arteritis

This observational study aims to enhance the description of the different ways Giant Cell Arteritis (GCA) affects vision. The latest technology and knowledge ar…

Italy762 participantsStarted 2024-06-27

Treatment: Fluorescein and Indocyanine green Angiography, High-resolution Optical Coherence Tomography

RecruitingNot Applicable

NCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical researc…

United States20,000 participantsStarted 2021-10-26

Treatment: Specimen sample

All recent trials (25 shown)

CompletedNot Applicable

NCT04390126

COVID-19 Related Lockdown Effects On Chronic Diseases

The containment associated with the VIDOC-19 pandemic creates an unprecedented societal situation of physical and social isolation. Our hypothesis is that in pa…

France1,343 participantsStarted 2020-04-14

Treatment: life questionnaires, questionnaire

CompletedNot Applicable

NCT06769412

A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg…

This study will describe and estimate the incidence of RV events among patients and patient eyes receiving aflibercept intravitreal (IVT) (Eylea® 2mg) therapy i…

United States550,000 participantsStarted 2025-07-01

Treatment: aflibercept 2 mg

Retinal Vasculitis

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Visual Involvement in Giant Cell Arteritis

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

All recent trials (25 shown)

COVID-19 Related Lockdown Effects On Chronic Diseases

A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg…

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Visual Involvement in Giant Cell Arteritis

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

All recent trials (25 shown)

COVID-19 Related Lockdown Effects On Chronic Diseases

A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg…

Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

Six-months Versus Nine-months ATT for Ocular TB

Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy

Optical Coherence Tomography (OCT) in Retinal Vasculitis

Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retin…

Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography

Biomarkers of Common Eye Diseases

Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Evaluation and Treatment of Patients With Inflammatory Eye Diseases

Biological Markers in Retinal Vasculitis

Stem Cell Transplantation in Ocular Lesions of Behcet's Disease

The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease

Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

HAT in Eye Complications of Behcet's Disease